Acadia pharmaceuticals jumps 6% after hours as FDA gives its new dementia drug “pimavanserin” a breakthrough classification as it enters Phase 3 trials.
Future of ACAD? Do you think there is more potential for them to sell if pimavanserin gets fda approval?
Noobie first post
Submitted October 04, 2017 at 10:27PM by Rubbyp_ http://ift.tt/2y0jhtr
